Institutional investors purchased a net $4.1 million shares of MDCO during the quarter ended September 2016 and now own 124.85% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TAVISTOCK LIFE SCIENCES CO. (INV... Bought 2.9 Million shares of Medicines Co
WELLS CAPITAL MANAGEMENT, INC. Bought 834.5 Thousand shares of Medicines Co
OPPENHEIMERFUNDS, INC. Bought 608.1 Thousand shares of Medicines Co